Projected Income Statement: Kering

Forecast Balance Sheet: Kering

Forecast Balance Sheet - Kering
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Net Debt 1 4,670 2,306 8,504 10,500 8,039 9,016 8,509 7,922
Change - -50.62% 268.78% 23.47% -23.44% 12.15% -5.62% -6.9%
Announcement Date 17/02/22 15/02/23 08/02/24 11/02/25 10/02/26 - - -
1EUR in Million
Estimates

Cash Flow Forecast: Kering

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
CAPEX 1 934 1,071 2,611 3,309 830 880.8 929 977.4
Change - 14.67% 143.79% 26.73% -74.92% 6.12% 5.47% 5.21%
Free Cash Flow (FCF) 1 3,942 3,208 1,983 1,400 2,300 1,741 1,656 1,908
Change - -18.61% -38.19% -29.4% 64.29% -24.29% -4.9% 15.24%
Announcement Date 17/02/22 15/02/23 08/02/24 11/02/25 10/02/26 - - -
1EUR in Million
Estimates

Forecast Financial Ratios: Kering

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028

Profitability

        
EBITDA Margin (%) 36.67% 35.65% 33.57% 27.14% 25.04% 26.08% 26.95% 28.42%
EBIT Margin (%) 28.43% 27.46% 24.26% 14.85% 11.11% 12.66% 14.86% 16.84%
EBT Margin (%) 25.64% 25.23% 21.63% 9.88% 3.09% 7.73% 11.4% 13.63%
Net margin (%) 18% 17.76% 15.25% 6.59% 0.49% 4.29% 7.03% 8.8%
FCF margin (%) 22.34% 15.76% 10.13% 8.14% 15.67% 11.94% 10.7% 11.58%
FCF / Net Income (%) 124.11% 88.77% 66.48% 123.57% 3,194.44% 278.17% 152.28% 131.63%

Profitability

        
ROA 10.75% 11.12% 7.92% 2.67% 1.26% 1.78% 2.72% 3.94%
ROE 25.24% 25.34% 19.37% 7.52% 3.59% 5% 7.63% 9.77%

Financial Health

        
Leverage (Debt/EBITDA) 0.72x 0.32x 1.29x 2.25x 2.19x 2.37x 2.04x 1.69x
Debt / Free cash flow 1.18x 0.72x 4.29x 7.5x 3.5x 5.18x 5.14x 4.15x

Capital Intensity

        
CAPEX / Current Assets (%) 5.29% 5.26% 13.34% 19.25% 5.66% 6.04% 6% 5.93%
CAPEX / EBITDA (%) 14.43% 14.76% 39.75% 70.9% 22.59% 23.16% 22.28% 20.88%
CAPEX / FCF (%) 23.7% 33.39% 131.67% 236.36% 36.09% 50.58% 56.1% 51.22%

Items per share

        
Cash flow per share 1 39.13 34.7 36.43 38.4 25.26 25.57 26.38 28.08
Change - -11.34% 5.01% 5.4% -34.23% 1.22% 3.2% 6.41%
Dividend per Share 1 12 14 14 6 3 3.412 4.93 6.444
Change - 16.67% 0% -57.14% -50% 13.74% 44.48% 30.72%
Book Value Per Share 1 107.6 114.5 124.1 121.6 119.9 122 128.7 136.9
Change - 6.47% 8.35% -2.04% -1.34% 1.7% 5.49% 6.41%
EPS 1 25.49 29.31 24.37 9.24 0.59 4.989 8.845 11.94
Change - 14.99% -16.85% -62.08% -93.61% 745.58% 77.29% 35.04%
Nbr of stocks (in thousands) 123,744 122,233 121,646 122,587 122,601 122,618 122,618 122,618
Announcement Date 17/02/22 15/02/23 08/02/24 11/02/25 10/02/26 - - -
1EUR
Estimates
2026 *2027 *
P/E 43.3x 24.4x
PBR 1.77x 1.68x
EV / Sales 2.43x 2.26x
Yield 1.58% 2.28%

EPS & Dividend

EPS & Dividend - Kering


Y-o-Y evolution of P/E

Valuation ratios - P/E - Kering
 

Year-on-year evolution of the Yield

Valuation ratios - Yield - Kering
Trader
Investor
Global
Quality
ESG MSCI
AA
MarketScreener Ratings - Kering
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
25
Last Close Price
215.85EUR
Average target price
264.80EUR
Spread / Average Target
+22.68%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Kering